Safety and efficacy of weekly 5-fluorouracil/ folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer

Background: Standard chemotherapy for patients with metastatic colorectal cancer (mCRC) or gastric cancer (GC) consists of two-drug, usually fluoropyrimidine-based, combinations, with or without the addition of biological agents. Studies of triple-drug regimens combining 5-fluorouracil (5-FU)/folini...

Full description

Bibliographic Details
Main Authors: Stefan Peinert, Wilfried Grothe, Alexander Stein, Lutz P. Müller, Joern Ruessel, Wieland Voigt, Hans-Joachim Schmoll, Dirk Arnold
Format: Article
Language:English
Published: SAGE Publishing 2010-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758834010365061